Rpo LLC Makes New $51,000 Investment in AC Immune SA (NASDAQ:ACIU)

Rpo LLC purchased a new stake in AC Immune SA (NASDAQ:ACIU) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 18,728 shares of the company’s stock, valued at approximately $51,000.

Separately, Geode Capital Management LLC increased its holdings in AC Immune by 9.9% in the 4th quarter. Geode Capital Management LLC now owns 64,090 shares of the company’s stock valued at $173,000 after purchasing an additional 5,794 shares during the last quarter. 51.36% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and set a $16.00 price target on shares of AC Immune in a research note on Friday, March 14th.

AC Immune Price Performance

Shares of NASDAQ:ACIU opened at $1.88 on Thursday. The firm has a market capitalization of $188.77 million, a PE ratio of -4.09 and a beta of 1.49. AC Immune SA has a 1 year low of $1.77 and a 1 year high of $4.98. The firm’s 50-day moving average is $2.43 and its two-hundred day moving average is $2.88.

AC Immune Profile

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.